Life WhispererLife WhispererLife WhispererLife Whisperer
  • How it works
  • Patients
  • Team
  • Clinics
  • Agents
  • News
  • IVF-X
  • Contact
  • Home
  • How it works
  • Team
  • Patients
  • Clinics
  • Agents
  • News
  • IVF-X
  • FAQs
  • Contact

Life Whisperer secures TechInSA funding to accelerate commercial growth of its embryo selection technology for IVF

IVF Embryo Selection

Life Whisperer, an AI startup in the fertility sector, has secured its first round of funding through the SA Early Commercialization Fund initiative administered by TechInSA. The fund is designed to support the commercialization of innovative technologies that have global market potential. 

The funding will support secondary validation of Life Whisperer’s approach, which applies AI-driven image analysis such as machine learning, as well as morphological assessment of embryos to assist in the selection of healthy embryos for IVF implantation.

Dr Michelle Perugini says “the South Australian government recognizes the value of providing support to companies with innovative ideas, and we hope to give back by building a world-leading capability for clinical decision support”.

Life Whisperer will use the funding to assist in the development of a scalable cloud-based software product that provides image analysis for embryo selection to clinics who perform IVF globally.

The value of Life Whisperer is that it is a completely non-invasive approach to analyzing embryos. Dr Jonathan Hall says “our approach does not require significant process change, does not tamper with the embryos, and does not require specialized hardware. This will hopefully reduce the barriers to use by clinics for this type of approach, and will see patients benefiting from the technology sooner.”

Life Whisperer plans to work with commercial partners to complete the next phase of validation.

For more information email Info@LifeWhisperer.co or Dr Michelle Perugini on +61 412 396 960.

Connect with us
Share
92

Related posts

December 1, 2020

Presagen announces IVF success story with first baby born globally aided by its artificial intelligence (AI) applied to medical imaging


Read more
July 2, 2020

AI fertility product Life Whisperer offers new hope to IVF patients in the UK and Europe following CE Mark approval


Read more
June 17, 2020

Life Whisperer Expands into India, Bangladesh and Sri Lanka Through Partnership with GoHealthe


Read more
February 24, 2020

Fertility Road Announces Exclusive Global Partnership With AI Company Life Whisperer


Read more

Comments are closed.

Life Whisperer
A product by
Presagen parent company to Life Whisperer

Published in Human Reproduction by Oxford University Press.

Oxford University Logo

HIPAA and GDPR compliant and ISO 13485 certified

CE Logo

Authorized for sale in the UK, Europe, Australia, New Zealand, Canada, India, Japan, Hong Kong, Singapore, Malaysia, and Vietnam

© Life Whisperer Diagnostics Pty Ltd     Terms and conditions   |   Privacy Policy   |   Fair Use Policy